Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes

Canadian Journal of Physiology and Pharmacology

Volumn 93, Issue 7, 2015, Pages 555-561

  Sturza, Adrian ^a   Duicu, Oana M ^a   Vaduva, Adrian ^a   Dănilă, Maria D ^a   Noveanu, Lavinia ^a   Varró, András ^b   Muntean, Danina M ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Clorgyline; Endothelial dysfunction; Experimental diabetes mellitus; Monoamine oxidases; Oxidative stress; Selegiline

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CLORGYLINE; SELEGILINE; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; ANIMAL; AORTA; CARDIAC MUSCLE; CARDIOVASCULAR DISEASES; COMPLICATION; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; WISTAR RAT;

ANIMALS; AORTA; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MONOAMINE OXIDASE; MYOCARDIUM; OXIDATIVE STRESS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN;

EID: 84943517017     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0544     Document Type: Article

References (34)

1. Al-Nuaimi, S.K., Mackenzie, E.M., and Baker, G.B. 2012. Monoamine oxidase inhibitors and neuroprotection: a review. Am. J. Ther. 19(6): 436-448. PMID: 22960850.
2. Bianchi, P., Kunduzova, O., Masini, E., Cambon, C., Bani, D., Raimondi, L., et al. 2005. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation, 112(21): 3297-3305. doi:10.1161/CIRCULATIONAHA.104.528133. PMID:16286591.
3. Binda, C., Aldeco, M., Geldenhuys, W.J., Tortorici, M., Mattevi, A., and Edmondson, D.E. 2011. Molecular insights into human monoamine oxidase B inhibition by the glitazone anti-diabetes drugs. ACS Med. Chem. Lett. 3(1): 39-42. doi:10.1021/ml200196p. PMID:22282722.
4. Bortolato, M., Chen, K., and Shih, J.C. 2008. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv. Drug Deliv. Rev. 60(13-14): 1527- 1533. PMID:18652859.
5. Brandes, R.P., and Schroder, K. 2008. Differential vascular functions of Nox family NADPH oxidases. Curr. Opin. Lipidol. 19(5): 513-518. doi:10.1097/MOL. 0b013e32830c91e3. PMID:18769233.
6. Carradori, S., and Petzer, J.P. 2015. Novel monoamine oxidase inhibitors: a patent review (2012-2014). Expert Opin. Ther. Pat. 25(1): 91-110. doi:10.1517/ 13543776.2014.982535. PMID:25399762.
7. de Chaumont, F., Dallongeville, S., Chenouard, N., Herve, N., Pop, S., Provoost, T., et al. 2012. Icy: an open bioimage informatics platform for extended reproducible research. Nat. Methods, 9(7): 690-696. doi:10.1038/ nmeth.2075. PMID:22743774.
8. Duicu, O., Sturza, A., Noveanu, L., and Muntean, D. 2013. Mitochondria and endothelial dysfunction: A glimpse of monoamine oxidases. Exp. Clin. Cardiol. 18(Suppl. A): 52A-56A.
9. Duicu, O.M., Lighezan, R., Sturza, A., Ceausu, R.A., Borza, C., Vaduva, A., et al. 2014. Monoamine oxidases as potential contributors to oxidative stress in diabetes: time for a study in patients undergoing heart surgery. BioMed Res. Int. Article ID 515437.
10. Edmondson, D.E. 2014. Hydrogen peroxide produced by mitochondrial monoamine oxidase catalysis: biological implications. Curr. Pharm. Des. 20(2): 155-160. PMID:23701542.
11. Giacco, F., and Brownlee, M. 2010. Oxidative stress and diabetic complications. Circ. Res. 107(9): 1058-1070. doi:10.1161/CIRCRESAHA.110.223545. PMID:21030723.
12. Guariguata, L., Whiting, D.R., Hambleton, I., Beagley, J., Linnenkamp, U., and Shaw, J.E. 2014. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pract. 103(2): 137-149. doi:10.1016/j.diabres. 2013.11.002. PMID:24630390.
13. Gupta, D., Kurhe, Y., and Radhakrishnan, M. 2014. Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system. Physiol. Behav. 129: 73-78. doi:10.1016/j.physbeh.2014.02.036. PMID:24582678.
14. Holscher, C. 2014. Drugs developed for treatment of diabetes show protective effects in Alzheimer's and Parkinson's diseases. Sheng Li Xue Bao, 66(5): 497-510. PMID:25331995.
15. Joshi, M., Kotha, S.R., Malireddy, S., Selvaraju, V., Satoskar, A.R., Palesty, A., et al. 2014. Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria. Mol. Cell. Biochem. 386(1-2): 233-249. doi:10.1007/s11010-013-1861-x. PMID:24307101.
16. Kaludercic, N., Takimoto, E., Nagayama, T., Feng, N., Lai, E.W., Bedja, D., et al. 2010. Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ. Res. 106(1): 193-202. doi:10.1161/CIRCRESAHA.109. 198366. PMID:19910579.
17. Kaludercic, N., Carpi, A., Nagayama, T., Sivakumaran, V., Zhu, G., Lai, E.W., et al. 2014a. Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts. Antioxid. Redox Signal. 20(2): 267-280. doi:10.1089/ars.2012.4616. PMID:23581564.
18. Kaludercic, N., Mialet-Perez, J., Paolocci, N., Parini, A., and Di, Lisa, F. 2014b. Monoamine oxidases as sources of oxidants in the heart. J. Mol. Cell. Cardiol. 73: 34-42. doi:10.1016/j.yjmcc.2013.12.032. PMID:24412580.
19. Kizub, I.V., Klymenko, K.I., and Soloviev, A.I. 2014. Protein kinase C in enhanced vascular tone in diabetes mellitus. Int. J. Cardiol. 174(2): 230-242. doi:10.1016/ j.ijcard.2014.04.117. PMID:24794552.
20. Manni, M.E., Zazzeri, M., Musilli, C., Bigagli, E., Lodovici, M., and Raimondi, L. 2013. Exposure of cardiomyocytes to angiotensin II induces over-activation of monoamine oxidase type A: implications in heart failure. Eur. J. Pharmacol. 718(1-3): 271-276. doi:10.1016/j.ejphar.2013.08.022. PMID:24012905.
21. Poon, C.C., Seto, S.W., Au, A.L., Zhang, Q., Li, R.W., Lee, W.Y., et al. 2010. Mitochondrial monoamine oxidase-A-mediated hydrogen peroxide generation enhances 5-hydroxytryptamine-induced contraction of rat basilar artery. Br. J. Pharmacol. 161(5): 1086-1098. doi:10.1111/j.1476-5381.2010.00941.x. PMID: 20977458.
22. Raasch, W., Bartels, T., Gieselberg, A., Dendorfer, A., and Dominiak, P. 2002. Angiotensin I-converting enzyme inhibition increases cardiac catecholamine content and reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated mechanism. J. Pharmacol. Exp. Ther. 300(2): 428-434. doi:10.1124/jpet.300.2.428. PMID:11805201.
23. Shih, J.C., Chen, K., and Ridd, M.J. 1999. Monoamine oxidase: from genes to behavior. Annu. Rev. Neurosci. 22: 197-217. doi:10.1146/annurev.neuro.22.1. 197. PMID:10202537.
24. Shiva, S. 2010. Mitochondria as metabolizers and targets of nitrite. Nitric Oxide, 22(2): 64-74. doi:10.1016/j.niox.2009.09.002. PMID:19788924.
25. Singh, V.P., Bali, A., Singh, N., and Jaggi, A.S. 2014. Advanced glycation end products and diabetic complications. Korean J. Physiol. Pharmacol. 18(1): 1-14. doi:10.4196/kjpp.2014.18.1.1. PMID:24634591.
26. Song, M.S., Matveychuk, D., MacKenzie, E.M., Duchcherer, M., Mousseau, D.D., and Baker, G.B. 2013. An update on amine oxidase inhibitors: multifaceted drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry, 44: 118-124. doi:10.1016/ j.pnpbp.2013.02.001. PMID:23410524.
27. Sturza, A., Leisegang, M.S., Babelova, A., Schroder, K., Benkhoff, S., Loot, A.E., et al. 2013a. Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta. Hypertension, 62(1): 140-146. doi:10.1161/HYPERTENSIONAHA. 113.01314. PMID:23670301.
28. Sturza, A., Mirica, S.N., Duicu, O., Gheorgheosu, D., Noveanu, L., Fira-Mladinescu, O., et al. 2013b. Monoamine oxidase-a inhibition reverses endothelial dysfunction in hypertensive rat aortic rings. Rev. Med. Chir. Soc. Med. Nat. Iasi, 117(1): 165-171. PMID:24505910.
29. Sturza, A., Noveanu, L., Duicu, O., and Muntean, D. 2014. P172Monoamine oxidase inhibition corrects endothelial dysfunction in experimental diabetes. Cardiovasc. Res. Suppl. 103: S9-S46. doi:10.1093/cvr/cvu082.108.
30. Thomas, T., McLendon, C., and Thomas, G. 1998. L-deprenyl: nitric oxide production and dilation of cerebral blood vessels. Neuroreport, 9(11): 2595-2600. doi:10.1097/00001756-199808030-00031. PMID:9721939.
31. Toth, E., Racz, A., Toth, J., Kaminski, P.M., Wolin, M.S., Bagi, Z., et al. 2007. Contribution of polyol pathway to arteriolar dysfunction in hyperglycemia. Role of oxidative stress, reduced NO, and enhanced PGH(2)/TXA(2) mediation. Am. J. Physiol. Heart Circ. Physiol. 293(5): H3096-H3104. PMID:17873009.
32. Xia, J., Wang, Z., and Zhang, F. 2014. Association between Related purine metabolites and diabetic retinopathy in type 2 diabetic patients. Int. J. Endocrinol. 2014: 651050. doi:10.1155/2014/651050. PMID:24688543.
33. Yamada, M., and Yasuhara, H. 2004. Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology, 25(1-2): 215-221. doi:10.1016/S0161- 813X(03)00097-4. PMID:14697896.
34. Youdim, M.B., Edmondson, D., and Tipton, K.F. 2006. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci. 7(4): 295-309. doi:10. 1038/nrn1883. PMID:16552415.